GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference

GRAIL (Nasdaq: GRAL) announced that company management will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11 at 10:00 a.m. ET.

Rhea-AI Summary

GRAIL (Nasdaq: GRAL) announced that company management will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, August 11 at 10:00 a.m. ET. Live and replay webcasts of the presentation will be available through the investor relations section of GRAIL's website, with the replay archived for at least 30 days.

Argus Jul 31 session 61 alerts

-3.63% close to close 0.8x rel. volume Open Argus

Details

News Market Reaction – GRAL

+8.0% Peak in 6 hr 7 min

$3.11B Market Cap

In the Jul 31 session, GRAL declined 3.63%, reflecting a moderate negative market reaction. Argus tracked a peak move of +8.0% during that session. Our momentum scanner triggered 61 alerts that day, indicating high trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

GRAIL's prior conference-presentation announcement was followed by 3.57%, giving this scheduling not...

Analysis

GRAIL's prior conference-presentation announcement was followed by 3.57%, giving this scheduling notice a directly comparable historical reference. The event remains informational, while moderate short positioning is a risk factor to monitor.

Key Figures

Conference edition: 46th Annual Presentation date: Aug. 11 Presentation time: 10:00 a.m. ET +1 more

Conference edition

46th Annual

Canaccord Genuity Growth Conference

Presentation date

Aug. 11

Canaccord Genuity Growth Conference

Presentation time

10:00 a.m. ET

Aug. 11 conference presentation

Webcast archive

at least 30 days

Replay availability after the event

Historical Context

5 past events · Latest: Jul 16

5 events

1. Jul 16

   Partnership announcement

   24h Move

   -3.2%

   Priority Health offered Galleri testing to self-insured employer groups in Michigan.

2. Jun 25

   Equity financing

   24h Move

   +3.1%

   GRAIL completed a $110 million financing with Samsung entities at $70.05 per share.

3. May 31

   Clinical data

   24h Move

   +0.0%

   PATHFINDER 2 results covered 35,878 adults and reported increased screen-detected cancers.

4. May 27

   Inducement grants

   24h Move

   +3.5%

   GRAIL granted RSUs covering 34,350 shares to 56 newly hired employees.

5. May 26

   Conference presentation

   24h Move

   +3.6%

   Management announced a June 9 presentation at the Goldman Sachs healthcare conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., July 30, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Tuesday, Aug. 11 at 10:00 a.m. ET. 

Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.

About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.

For more information, visit grail.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-canaccord-genuity-46th-annual-growth-conference-302839418.html

SOURCE GRAIL, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will GRAIL (Nasdaq: GRAL) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

GRAIL will present on Tuesday, August 11, 2026, at 10:00 a.m. ET. According to GRAIL, the presentation is part of the Canaccord Genuity 46th Annual Growth Conference in Boston and will be accessible via webcast.

How can investors access the GRAIL (GRAL) webcast for the Canaccord Genuity 46th Annual Growth Conference?

Investors can access the live and replay webcasts through the investor relations section of GRAIL's website. According to GRAIL, the webcast links will be available at investors.grail.com for convenient online viewing.

Will a replay of GRAIL's 2026 Canaccord Genuity conference presentation be available for GRAL shareholders?

Yes, a replay will be available for at least 30 days after the event. According to GRAIL, the archived webcast can be accessed in the investor relations section of its website following the live presentation.

Where is the 2026 Canaccord Genuity 46th Annual Growth Conference featuring GRAIL (GRAL) being held?

The conference presentation by GRAIL will take place in Boston. According to GRAIL, while the physical event is in Boston, investors can follow the session remotely via the company’s online webcast.

What type of company is GRAIL (Nasdaq: GRAL) presenting at the Canaccord Genuity 2026 conference?

GRAIL is a healthcare company focused on early cancer detection. According to GRAIL, its mission is to detect cancer early, when it can be cured, and it will discuss its business at the conference presentation.